Unknown OBSERVATIONAL NCT05261737

Steroid Injection in De Quervain Tenosynovitis

Effectiveness of Steroid Injection in Treating Pain in De Quervain Tenosynovitis

Sponsor: National University Hospital, Singapore

Updated 4 times since 2022 Last updated: Feb 20, 2022 Started: Mar 14, 2019 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on De Quervain Disease, this trial is ongoing. The trial is conducted by National University Hospital, Singapore and has accumulated 4 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Apr 2022 — Mar 2024 [monthly]

Recruiting

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National University Hospital, Singapore

Data source: National University Hospital, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore